QingSong Health (HKSE:02661) Total Equity: HK$1,107 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02661 QingSong Health Corp HKSE:02661
18 GF Score
Price HK$5.89
! 4 Warning Signs
View Full Analysis

What is QingSong Health Total Equity?

QingSong Health HKSE:02661 +2.17% 18 Total Equity is HK$1,107 Mil as of Dec. 2025. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 4 warning signs investors should review.

QingSong Health's total equity for the quarter that ended in Dec. 2025 was HK$1,107 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

QingSong Health Total Equity Historical Data

* Premium members only.

The historical data trend for QingSong Health's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QingSong Health Total Equity Chart

QingSong Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Equity
-1,385.55 -1,310.26 -1,301.01 1,107.18

QingSong Health Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial -1,310.26 0.00 -1,301.01 -1,236.57 1,107.18
HKSE:02661
18GF Score
QingSong Health Corp HKSE:02661
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QingSong Health Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

QingSong Health's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1316.776-209.596
=1,107

QingSong Health's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1316.776-209.596
=1,107

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$1,107 Mil mean?
QingSong Health (HKSE:02661) has a Total Equity of HK$1,107 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for QingSong Health and its competitors.
Is QingSong Health's Total Equity too high?
QingSong Health's current Total Equity is HK$1,107 Mil. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's Total Equity compare to VEEV and BTSG?
QingSong Health's Total Equity of HK$1,107 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for QingSong Health and its competitors. QingSong Health's current Total Equity is HK$1,107 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current Total Equity of HK$1,107 Mil. The current Total Equity is HK$1,107 Mil. QingSong Health's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current Total Equity is HK$1,107 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QingSong Health Business Description

Address No. 28 Andingmen East Street, 7th floor, Building F, Yonghe Mansion, Dongcheng District, Beijing, CHN
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score

Get the complete analysis for HKSE:02661

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.89
Price